6.2 Schedule III-V Dispensing, Refill Limits & Non-Rx Controls

6.2 Schedule III-V Dispensing, Refill Limits & Non-Rx Controls

Prescriptions for controlled substances in Schedules III, IV, and V carry lower abuse potential than Schedule II agents but remain subject to strict statutory dispensing caps, refill ceilings, and recordkeeping mandates under both federal law (21 CFR § 1306.22) and Kentucky law (KRS Chapter 218A and Title 201 KAR Chapter 2).

1. Schedule III–V Prescription Validity & Refill Rules

Prescriptions for Schedule III, IV, and V controlled substances are governed by standardized expiration and refill parameters:

┌─────────────────────────────────────────────────────────────────────────────┐
│             SCHEDULE III, IV, AND V DISPENSING PARAMETERS                   │
├──────────────────────────────────┬──────────────────────────────────────────┤
│ Prescription Validity Window     │ Maximum 6 months (180 days) from date    │
│                                  │ of issuance (KRS 218A.180 / 201 KAR).    │
├──────────────────────────────────┼──────────────────────────────────────────┤
│ Maximum Number of Refills        │ Maximum 5 refills within 6 months        │
│                                  │ (whichever occurs first).                │
├──────────────────────────────────┼──────────────────────────────────────────┤
│ Permissible Transmission Methods │ Electronic (EPCS mandated unless exempt) │
│                                  │ Written (Kentucky Security Blank), Oral  │
│                                  │ (reduced to writing), Faxed.             │
├──────────────────────────────────┼──────────────────────────────────────────┤
│ Refill Authorizations after      │ Treated as a BRAND-NEW prescription      │
│ 5 Refills or 6 Months            │ (requires new prescription number).      │
└──────────────────────────────────┴──────────────────────────────────────────┘

Oral and Faxed Prescriptions

• Oral Orders: A pharmacist or registered pharmacy intern (under direct supervision) may accept oral prescriptions for Schedule III, IV, and V medications from a practitioner or their authorized agent. The pharmacist/intern must immediately reduce the oral order to writing containing all required prescription elements.
• Faxed Orders: Faxed Schedule III–V prescriptions are legally valid as original orders, provided they bear the prescriber's manual signature (or secure electronic signature where permitted) and are written on an approved Kentucky Security Prescription Blank.

State Scheduling Specifics in Kentucky

• Gabapentin (Neurontin): Classified as a Schedule V controlled substance under Kentucky administrative regulations (902 KAR 55:015). Prescriptions for gabapentin are subject to the 6-month expiration window, 5-refill maximum, mandatory KASPER reporting within 1 business day, and controlled substance storage/transfer rules.
• Fioricet (Butalbital / APAP / Caffeine): Classified as a Schedule III controlled substance in Kentucky (902 KAR 55:045), despite federal regulations exempting it from federal scheduling. In Kentucky, Fioricet requires a security blank, expires in 6 months, and cannot exceed 5 refills.

2. Refill Recordkeeping: Manual vs. Electronic Data Processing Systems

Under 21 CFR § 1306.22 and 201 KAR 2:171, a pharmacy must maintain an accurate, immutable audit trail of all controlled substance refills.

Manual (Paper) System

If a pharmacy maintains a manual paper-based filing system, each refill must be recorded on the back of the original paper prescription with:

1. The date of the refill;
2. The quantity dispensed;
3. The dispensing pharmacist's initials.

Electronic Automated Data Processing (ADP) System

Modern community and institutional pharmacies utilize electronic recordkeeping systems. When an ADP system is used for Schedule III–V refills, it must provide online retrieval of original prescription details and complete refill histories.

┌─────────────────────────────────────────────────────────────────────────────┐
│         MANDATORY DAILY ADP PHARMACIST VERIFICATION PROTOCOLS               │
├─────────────────────────────────────────────────────────────────────────────┤
│ METHOD A: Daily Hard-Copy Printout (Standard Option)                        │
│ • Printout generated within 72 hours of the date of dispensing.             │
│ • Contains complete refill audit trail for all controlled substances.       │
│ • Each dispensing pharmacist who refilled prescriptions on that day MUST    │
│   verify the accuracy of their entries, date the printout, and sign it      │
│   (manual wet signature) as a legal document.                               │
│                                                                             │
│ METHOD B: Daily Bound Logbook / Separate File (Alternative Option)          │
│ • In lieu of a printout, the pharmacy maintains a bound logbook or separate │
│   file where each dispensing pharmacist signs a statement daily certifying   │
│   that the refill data entered into the system for that day was reviewed,   │
│   verified, and is accurate.                                                │
│                                                                             │
│ Centralized Retrieval Requirement:                                          │
│ • Any computerized system must be capable of generating a hard-copy printout│
│   of refill data within 48 hours upon request by DEA or Board inspectors.   │
└─────────────────────────────────────────────────────────────────────────────┘

3. Partial Filling of Schedule III, IV, and V Prescriptions

Partial dispensing of Schedule III, IV, and V controlled substances is explicitly permitted under federal regulation (21 CFR § 1306.23) and Kentucky law, provided the following legal constraints are strictly respected:

1. Recording: Each partial dispensing is recorded in the exact same manner as a refill (recording date, quantity dispensed, dispensing pharmacist ID, and remaining balance).
2. Total Quantity Cap: The total cumulative quantity dispensed across all partial fills cannot exceed the total quantity originally authorized by the prescriber (original quantity plus any authorized refills).
3. 6-Month Cutoff: No dispensing of any partial fill may occur beyond six (6) months from the date of issuance of the prescription.

┌─────────────────────────────────────────────────────────────────────────────┐
│             PARTIAL FILLS VS. REFILLS: THE MPJE DISTINCTION                 │
├─────────────────────────────────────────────────────────────────────────────┤
│ Scenario: Prescription for Zolpidem 10 mg (C-IV) #30 with 5 refills.        │
│ Total Authorized Quantity = 30 + (5 × 30) = 180 tablets.                    │
│ Validity Window = 6 months from date written.                               │
│                                                                             │
│ • Patient requests 15 tablets every two weeks.                              │
│ • Over 4 months, the pharmacy dispenses 15 tablets on 8 separate occasions  │
│   (Total dispensed = 120 tablets).                                          │
│                                                                             │
│ Legal Analysis:                                                             │
│ ✔ Permissible: Partial fills do NOT count as a 'full refill' against the 5- │
│   refill limit, provided total dispensed (120) <= authorized total (180)    │
│   and all dispensing occurs within 6 months of issuance.                    │
└─────────────────────────────────────────────────────────────────────────────┘

4. Non-Prescription Schedule V Sales in Kentucky (KRS 218A.190 / 902 KAR 55:015 §6)

Kentucky permits the pharmacist sale of exempt Schedule V codeine preparations without a prescription. What Kentucky adds on top of the federal rule is a seven-element statutory checklist. Every element must be satisfied; failing any one makes the sale unlawful.

┌─────────────────────────────────────────────────────────────────────────────┐
│        KRS 218A.190 — EXEMPT CODEINE SALE CHECKLIST (ALL 7 REQUIRED)        │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. COMPOSITION: <= 200 mg codeine (or its salts) per 100 mL or per 100 g.   │
│ 2. FORMULATION: Contains additional (non-narcotic) medicinal ingredients.   │
│ 3. PURPOSE:     Sold in good faith as a medicine — not for abuse/diversion. │
│ 4. DISPENSER:   Dispensed by a PHARMACIST (not a technician, not an intern).│
│ 5. AGE:         Purchaser is 18 years of age or older.                      │
│ 6. DISPLAY:     Product is NOT publicly displayed (kept behind the counter).│
│ 7. QUANTITY:    <= 120 mL sold to one person within any 48-hour period.     │
├─────────────────────────────────────────────────────────────────────────────┤
│ PLUS: a SEPARATE REGISTRY (KRS 218A.190(3)) recording the date, purchaser   │
│ name and address, preparation name, quantity, and the dispenser's name.     │
│ PLUS: CHFS may prohibit any specific codeine preparation from non-Rx sale   │
│ on evidence of actual or potential abuse (KRS 218A.190(4)).                 │
└─────────────────────────────────────────────────────────────────────────────┘

Exam Trap — the direction of the Kentucky deviation. Kentucky is stricter than federal law on scheduling (gabapentin, nalbuphine, butalbital, pentazocine, phenobarbital) — which trains candidates to answer "Kentucky bans it" reflexively. Exempt codeine sales run the other way: Kentucky allows them and layers on conditions. If an item asks whether a 35-year-old with valid ID may buy 120 mL of Cheratussin AC without a prescription, the answer is yes, provided the pharmacist personally makes the sale, the product was not on open display, and the registry entry is made. Note also that many chain employers prohibit these sales by corporate policy — that is a policy restriction, not the law.

5. Pseudoephedrine & Ephedrine Sales Restrictions (KRS 218A.1446)

Pseudoephedrine, ephedrine, and phenylpropanolamine are heavily regulated precursor chemicals used in the illicit manufacture of methamphetamine. The federal Combat Methamphetamine Epidemic Act (CMEA) of 2005 and Kentucky's stricter statute (KRS 218A.1446) establish rigorous retail sales controls.

Comprehensive Federal vs. Kentucky Sales Limits

NPLEx (National Precursor Log Exchange) Operational Mechanics

• Real-Time Stop-Sale System: Before completing any retail sale of pseudoephedrine or ephedrine, the pharmacy employee must transmit the purchaser's identifying information and product data to NPLEx.
• Stop-Sale Alerts: If NPLEx calculates that the transaction will cause the purchaser to exceed the 3.6 g daily limit, the 7.2 g 30-day limit, or the 24 g annual limit, NPLEx generates a stop-sale alert. The pharmacy employee is legally prohibited from completing the sale and must provide the purchaser with written instructions on how to contest the alert.
• System Downtime Protocol: If the NPLEx system experiences a technical outage, the pharmacy must maintain a manual paper logbook recording the purchaser's name, address, date of birth, photo ID type and number, product purchased, quantity in grams, date and time, and signature. The pharmacy must enter this data into NPLEx within 72 hours after system restoration.

Grams Base Calculation High-Yield Reference

To calculate pseudoephedrine base content for exam questions:

• Pseudoephedrine HCl 30 mg tablet: Contains approximately 24.6 mg (0.0246 g) of base (~82% base).
• Pseudoephedrine Sulfate 30 mg tablet: Contains approximately 23.2 mg (0.0232 g) of base (~77% base).
• Quick Estimation Rule: A box of 24 tablets of Pseudoephedrine HCl 30 mg contains 24 * 24.6 mg = 590.4 mg = 0.59 grams base. A customer can purchase up to 146 tablets of 30 mg HCl per day (146 * 0.0246 g = 3.59 g <= 3.6 g).